|
2025
|
Invention
|
Heterocyclyl beta-hydroxy alkyl amines and their use in the treatment of hyperglycaemia and disor... |
|
|
Invention
|
Cycloalkyl or heterocycloalkyl beta-hydroxy alkyl amines and their use in the treatment of hyperg... |
|
|
Invention
|
2-adrenergic receptor agonists in treating muscle wasting. 22-adrenergic receptor agonist, or a p... |
|
|
Invention
|
Combinations of beta 2-adrenergic receptor agonists and sglt2 inhibitors for use in treating hype... |
|
2024
|
Invention
|
Heteroaryl substituted beta-hydroxyethylamines for use in treating hyperglycaemia.
There is here... |
|
|
Invention
|
Heterocycloalkyl beta-hydroxy alkyl amines for use in the treatment of hyperglycaemia and disorde... |
|
|
Invention
|
Cyclohexyl or heterocycloalkyl beta-hydroxy alkyl amines for use in the treatment of hyperglycaem... |
|
|
Invention
|
Substituted hydroxymethyl pyrrolidines for use in the treatment of hyperglycaemia and disorders c... |
|
|
Invention
|
Combination of beta-2-adrenergic receptor agonists and glp-1 receptor agonists for use in treatin... |
|
|
Invention
|
Combinations of beta 2-adrenergic receptor agonists and metformin for use in treating obesity and... |
|
|
Invention
|
Beta 2-adrenergic receptor agonists for treatment or prevention of muscle wasting.
There is here... |
|
|
Invention
|
Beta 2-adrenergic receptor agonists for treatment or prevention of muscle wasting. 22-adrenergic ... |
|
2023
|
Invention
|
Combinations of beta 2-adrenergic receptor agonists and beta 3-adrenergic receptor agonists, and ... |
|
|
Invention
|
Fluorophenyl beta-hydroxyethylamines and their use in the treatment of hyperglycaemia. There is h... |
|
|
Invention
|
Hydroxymethyl azabicyclo[2.2.1]heptanes and medical uses thereof.
There are provided herein comp... |
|
|
Invention
|
Hydroxymethyl azabicyclo[2.2.1]heptanes and medical uses thereof. There are provided herein compo... |
|
2022
|
Invention
|
Crystalline form of (r)-2-(tert-butylamino)-1-(5-fluoropyridin-3-yl)-ethan-1-ol hemi-tartrate sal... |
|
|
Invention
|
Cyclohexyl beta-hydroxy alkyl amines and medical uses thereof.
There is provided herein compound... |
|
|
Invention
|
Substituted hydroxymethyl pyrrolidines and medical uses thereof.
There is provided herein compou... |
|
|
Invention
|
Cyclohexyl beta-hydroxy alkyl amines and medical uses thereof. There is provided herein compounds... |
|
|
Invention
|
Substituted hydroxymethyl pyrrolidines and medical uses thereof. There is provided herein compoun... |
|
|
Invention
|
Heteroaryl substituted beta-hydroxyethylamines for use in treating hyperglycaemia. 3, have meanin... |
|
2021
|
Invention
|
Arylazabicyclo[2.1.1]hexylmethanols derivatives and medical uses thereof.
There is provided here... |
|
|
Invention
|
Hydroxylbenzyl azabicyclo[2.2.1]heptan-1-ane drivatives and medical uses thereof.
There is provi... |
|
|
Invention
|
Hydroxylbenzyl azabicyclo[2.2.1]heptan-1-ane drivatives and medical uses thereof. There is provid... |
|
|
Invention
|
Arylazabicyclo[2.1.1]hexylmethanol derivatives and medical uses thereof. There is provided herein... |
|
|
Invention
|
Combinations of adrenergic receptor agonists for the treatment of type 2 diabetes.
There is here... |
|
2020
|
Invention
|
Heteroaryl(heterocyclyl)methanol compounds useful in the treatment of hyperglycaemia. 1 and ring ... |
|
|
Invention
|
Heterocyclyl(phenyl)methanol compounds useful in the treatment of hyperglycaemia.
There is herei... |
|
|
Invention
|
Heteroaryl(heterocyclyl)methanol compounds useful in the treatment of hyperglycaemia. There is he... |
|
|
Invention
|
Heterocyclyl(phenyl)methanol compounds useful in the treatment of hyperglycaemia. There is herein... |
|
2018
|
Invention
|
Beta-hydroxy heterocyclic amines and their use in the treatment of hyperglycaemia. 1, ring A, m a... |
|
|
Invention
|
Chiral beta-hydroxyethylamines and their use in the treatment of hyperglycemia. 4 and n have mean... |
|
|
Invention
|
Beta-hydroxy heterocyclic amines and their use in the treatment of hyperglycaemia. There is herei... |
|
2017
|
Invention
|
Compounds for the treatment of hyperglycaemia.
There is herein provided a compound of formula (I... |
